{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:55:23Z","timestamp":1791492923170,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015862","name":"Chinese Nutrition Society","doi-asserted-by":"publisher","award":["CYP1A2"],"award-info":[{"award-number":["CYP1A2"]}],"id":[{"id":"10.13039\/100015862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015862","name":"Chinese Nutrition Society","doi-asserted-by":"publisher","award":["CYP2C8"],"award-info":[{"award-number":["CYP2C8"]}],"id":[{"id":"10.13039\/100015862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.abb.2025.110504","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T02:42:08Z","timestamp":1749523328000},"page":"110504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Synthesis of novel pyrazino[1,2-a]indol-1(2H)-one derivatives as potent cholinesterase inhibitors and their in vitro and in silico evaluations"],"prefix":"10.1016","volume":"771","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7305-7177","authenticated-orcid":false,"given":"Burak","family":"Kuzu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2025.110504_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chempr.2018.01.012","article-title":"Bioactive compound collections: from design to target identification","volume":"4","author":"Laraia","year":"2018","journal-title":"Chem"},{"key":"10.1016\/j.abb.2025.110504_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acs.jmedchem.8b00760","article-title":"Polypharmacology by design: a medicinal chemist's perspective on multitargeting compounds","volume":"62","author":"Proschak","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2025.110504_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/627375","article-title":"New perspectives on how to discover drugs from herbal medicines: CAM's outstanding contribution to modern therapeutics","volume":"2013","author":"Pan","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.abb.2025.110504_bib4","doi-asserted-by":"crossref","first-page":"30781","DOI":"10.1039\/D1RA03718H","article-title":"The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020","volume":"11","author":"Kareem","year":"2021","journal-title":"RSC Adv."},{"issue":"7","key":"10.1016\/j.abb.2025.110504_bib5","first-page":"1170","article-title":"A comprehensive review on Alzheimer's disease","volume":"10","author":"Anwal","year":"2021","journal-title":"World J. Pharm. Pharmaceut. Sci."},{"issue":"6","key":"10.1016\/j.abb.2025.110504_bib6","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic signaling in Alzheimer's disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules (Basel)"},{"issue":"8","key":"10.1016\/j.abb.2025.110504_bib7","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3390\/ijms26083781","article-title":"Structural bioinformatics applied to acetylcholinesterase enzyme inhibition","volume":"26","author":"Reynoso-Garc\u00eda","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.abb.2025.110504_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targeting acetylcholinesterase and butyrylcholinesterase in dementia","volume":"9","author":"Lane","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.abb.2025.110504_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116463","article-title":"Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease","volume":"272","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.abb.2025.110504_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31274","article-title":"New paradigms in the study of the cholinergic system and metabolic diseases: acetyl- and butyrylcholinesterase","volume":"239","author":"Villeda-Gonz\u00e1lez","year":"2024","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.abb.2025.110504_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/ADR-210061","article-title":"Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer's disease and future perspectives","volume":"6","author":"Moreira","year":"2022","journal-title":"J. Alzheimers Dis. Rep"},{"key":"10.1016\/j.abb.2025.110504_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11011-022-00921-w","article-title":"Alzheimer's disease therapy based on acetylcholinesterase inhibitor\/blocker effects on voltage-gated potassium channels","volume":"37","author":"Li","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.abb.2025.110504_bib13","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1039\/C5TX00096C","article-title":"The acute hepatotoxicity of tacrine explained by 1H NMR based metabolomic profiling","volume":"4","author":"Lou","year":"2015","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.abb.2025.110504_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/ph14080779","article-title":"Synthesis and biological activities of pyrazino [1,2-a] indole and pyrazino [1,2-a] indol-1-one derivatives","volume":"14","author":"Zhang","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.abb.2025.110504_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejmech.2018.01.042","article-title":"Design, synthesis, mechanistic and histopathological studies of small-molecules of novel indole-2-carboxamides and pyrazino [1,2-a] indol-1 (2H)-ones as potential anticancer agents effecting the reactive oxygen species production","volume":"146","author":"Youssif","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.abb.2025.110504_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1039\/C5MD00439J","article-title":"Novel indole\u2013flutimide heterocycles with activity against influenza PA endonuclease and hepatitis C virus","volume":"7","author":"Zoidis","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.abb.2025.110504_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ardp.19943270811","article-title":"Structure\u2010activity relationship studies of CNS agents, XV: N\u2010[\u03c9\u2010(4\u2010aryl\u20101\u2010piperazinyl) alkyl]\u20102\u2010oxo\u20101,2,3,4\u2010tetrahydroquinolines and\u20104\u2010oxo\u20101,2,3,4\u2010tetrahydropyrazino [1,2\u2010a] indoles: new, highly potent 5\u2010HT1A ligands","volume":"327","author":"Mokrosz","year":"1994","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.abb.2025.110504_bib18","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.1016\/j.bmcl.2010.08.009","article-title":"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino [1,2-a] indol-1-one scaffold","volume":"20","author":"Richter","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.abb.2025.110504_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.abb.2025.110504_bib20","first-page":"115","article-title":"History of alzheimer's disease, dement. Neurocogn","volume":"15","author":"Yang","year":"2016","journal-title":"Disord."},{"key":"10.1016\/j.abb.2025.110504_bib21","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1039\/C5MD00274E","article-title":"Tricyclic phenothiazine and phenoselenazine derivatives as potential multi-targeting agents to treat Alzheimer's disease","volume":"6","author":"Tin","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.abb.2025.110504_bib22","article-title":"Design, synthesis and structure-activity relationship studies of 3-phenylpyrazino [1,2-a] indol-1 (2H)-ones as amyloid aggregation and cholinesterase inhibitors with antioxidant activity","volume":"6","author":"Gujral","year":"2022","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.abb.2025.110504_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/pharmaceutics16020281","article-title":"New multitarget rivastigmine\u2013indole hybrids as potential drug candidates for Alzheimer's disease","volume":"16","author":"Bon","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.abb.2025.110504_bib24","doi-asserted-by":"crossref","first-page":"9865","DOI":"10.1080\/07391102.2022.2148126","article-title":"Synthesis of indole derivatives as Alzheimer inhibitors and their molecular docking study","volume":"41","author":"Homoud","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.abb.2025.110504_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103844","article-title":"Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer's disease","volume":"99","author":"Liao","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.abb.2025.110504_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4155\/fmc-2022-0228","article-title":"New indole derivatives as multitarget anti-Alzheimer's agents: synthesis, biological evaluation and molecular dynamics","volume":"15","author":"Azmy","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.abb.2025.110504_bib27","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1021\/acschemneuro.9b00503","article-title":"Fascaplysin derivatives are potent multitarget agents against Alzheimer's disease: in vitro and in vivo evidence","volume":"10","author":"Pan","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.abb.2025.110504_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1515\/znb-2020-0205","article-title":"A convenient one-pot approach to the synthesis of novel pyrazino [1,2-a] indoles fused to heterocyclic systems and evaluation of their biological activity as acetylcholinesterase inhibitors","volume":"76","author":"Ashram","year":"2021","journal-title":"Z. Naturforsch. B Chem. Sci."},{"key":"10.1016\/j.abb.2025.110504_bib29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11030-024-10828-6","article-title":"Structure-based inhibition of acetylcholinesterase and butyrylcholinesterase with 2-aryl-6-carboxamide benzoxazole derivatives: synthesis, enzymatic assay, and in silico studies","volume":"29","author":"Kuzu","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.abb.2025.110504_bib30","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s11696-025-03947-3","article-title":"Imidazo [1,2-a] pyridine Mannich bases: synthesis, anticholinesterase evaluation, and in silico studies","volume":"79","author":"Kuzu","year":"2025","journal-title":"Chem. Pap."},{"key":"10.1016\/j.abb.2025.110504_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.abb.2025.110504_bib32","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.abb.2025.110504_bib33","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.abb.2025.110504_bib34","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2025.110504_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.abb.2025.110504_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202401673","article-title":"Discovery of new pyrazole\u2010tosylamide derivatives as apoptosis inducers through BCL\u20102 inhibition and caspase\u20103 activation","volume":"22","author":"Kuzu","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.abb.2025.110504_bib37","first-page":"378","article-title":"Design of new drugs for the treatment of Alzheimer's disease based on tacrine structure","volume":"14","author":"De-Aquino","year":"2013","journal-title":"Curr. Drug Targets"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986125002176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986125002176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T07:54:42Z","timestamp":1752566082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986125002176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"alternative-id":["S0003986125002176"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2025.110504","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of novel pyrazino[1,2-a]indol-1(2H)-one derivatives as potent cholinesterase inhibitors and their in vitro and in silico evaluations","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2025.110504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110504"}}